Concord Medical Co., Ltd. (TPEX:6518)
27.30
-0.05 (-0.18%)
At close: Mar 27, 2026
Concord Medical Revenue
In the year 2025, Concord Medical had annual revenue of 964.35M TWD with 8.37% growth. Concord Medical had revenue of 448.81M in the half year ending June 30, 2025, with 11.25% growth.
Revenue
964.35M
Revenue Growth
+8.37%
P/S Ratio
0.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
910.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 964.35M | 74.51M | 8.37% |
| Dec 31, 2024 | 889.85M | 56.64M | 6.80% |
| Dec 31, 2023 | 833.20M | -56.00M | -6.30% |
| Dec 31, 2022 | 889.21M | 150.22M | 20.33% |
| Dec 31, 2021 | 738.99M | -70.72M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.25B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bionime | 1.84B |
| Chi Sheng Pharma & Biotech | 1.38B |
| ICARES Medicus | 1.13B |
| Crystalvue Medical | 949.05M |
| Maxigen Biotech | 811.56M |
| Unicon Optical | 747.16M |